• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story.

作者信息

Lipman J, Udy A A, Roberts J A

出版信息

Anaesth Intensive Care. 2011 Nov;39(6):999-1000. doi: 10.1177/0310057X1103900602.

DOI:10.1177/0310057X1103900602
PMID:22165348
Abstract
摘要

相似文献

1
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story.我们是否了解重症监护病房中生理机能改变、后续干预措施及由此产生的临床情况所带来的影响？抗生素的情况。
Anaesth Intensive Care. 2011 Nov;39(6):999-1000. doi: 10.1177/0310057X1103900602.
2
Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.治疗重症患者耐甲氧西林金黄色葡萄球菌肺炎的万古霉素最佳剂量
Anaesth Intensive Care. 2011 Nov;39(6):1030-7. doi: 10.1177/0310057X1103900608.
3
Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?万古霉素，对耐甲氧西林金黄色葡萄球菌医院获得性肺炎无敌有效？真的吗？
Crit Care Med. 2010 Sep;38(9):1910-2. doi: 10.1097/CCM.0b013e3181f11ad9.
4
First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary.
J Chemother. 2008 Oct;20(5):655-6. doi: 10.1179/joc.2008.20.5.655.
5
Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly.万古霉素用于耐甲氧西林金黄色葡萄球菌肺炎：利弊与隐忧
Crit Care Med. 2012 Jan;40(1):330-2. doi: 10.1097/CCM.0b013e31822e5741.
6
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌所致复杂性皮肤和皮肤结构感染及医院获得性肺炎中体重对治疗效果和安全性的影响。
Clin Ther. 2013 Oct;35(10):1557-70. doi: 10.1016/j.clinthera.2013.08.001. Epub 2013 Sep 3.
7
Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications.利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌肺炎的比较：机构层面的影响
Pharmacotherapy. 2016 Jul;36(7):731-9. doi: 10.1002/phar.1771. Epub 2016 Jun 30.
8
Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.耐甲氧西林金黄色葡萄球菌医院获得性肺炎的药物治疗。
Ann Pharmacother. 2012 Dec;46(12):1678-87. doi: 10.1345/aph.1R370. Epub 2012 Dec 11.
9
Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.在一个全国退伍军人事务部耐甲氧西林金黄色葡萄球菌肺炎队列中临床成功的预测因素。
Clin Ther. 2014 Apr 1;36(4):552-9. doi: 10.1016/j.clinthera.2014.02.013. Epub 2014 Mar 14.
10
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.万古霉素与利奈唑胺治疗耐甲氧西林金黄色葡萄球菌医院获得性肺炎：ZEPHyR 试验的意义。
Ann Pharmacother. 2012 Oct;46(10):1432-5. doi: 10.1345/aph.1R221. Epub 2012 Sep 4.

引用本文的文献

1
Multistate modeling for survival analysis in critically ill patients treated with meropenem.多州建模分析美罗培南治疗危重症患者的生存情况。
CPT Pharmacometrics Syst Pharmacol. 2024 Feb;13(2):222-233. doi: 10.1002/psp4.13072. Epub 2023 Nov 7.
2
Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone.脓毒症期间的药代动力学参数随时间的变化，以及接受头孢曲松治疗的危重症儿童和青年患者的达标情况与结局的相关性。
Pharmacotherapy. 2023 Jul;43(7):609-621. doi: 10.1002/phar.2774. Epub 2023 Feb 14.
3
Therapeutic Drug Monitoring of Levoffoxacin in an Obese Adolescent: A Case Report.
一名肥胖青少年左氧氟沙星的治疗药物监测：病例报告
J Pediatr Pharmacol Ther. 2020;25(3):261-265. doi: 10.5863/1551-6776-25.3.261.
4
Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report.多药耐药铜绿假单胞菌长时间输注氨曲南的治疗药物监测：一例报告
J Pediatr Pharmacol Ther. 2017 Nov-Dec;22(6):467-470. doi: 10.5863/1551-6776-22.6.467.
5
Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy.持续肾脏替代治疗的儿科患者中持续输注多利培南的治疗药物监测
J Pediatr Pharmacol Ther. 2017 Jan-Feb;22(1):69-73. doi: 10.5863/1551-6776-22.1.69.
6
Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.持续输注美罗培南并同时进行体外生命支持和连续性肾脏替代治疗的药代动力学：一例报告
J Pediatr Pharmacol Ther. 2016 Jan-Feb;21(1):92-7. doi: 10.5863/1551-6776-21.1.92.
7
Fosfomycin: Resurgence of an old companion.磷霉素：老伙伴的复兴。
J Infect Chemother. 2016 May;22(5):273-80. doi: 10.1016/j.jiac.2016.01.010. Epub 2016 Feb 28.
8
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?对于肌酐清除率增加的重症患者，哌拉西林的标准剂量是否足够？
Crit Care. 2015 Jan 30;19(1):28. doi: 10.1186/s13054-015-0750-y.
9
Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.确定危重症患者肾脏药物清除增加的潜在机制：外源性标记化合物的应用。
Crit Care. 2014 Nov 29;18(6):657. doi: 10.1186/s13054-014-0657-z.
10
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.危重症患者经验性使用β-内酰胺类抗生素治疗时目标未达到的危险因素。
Intensive Care Med. 2014 Sep;40(9):1340-51. doi: 10.1007/s00134-014-3403-8. Epub 2014 Jul 23.